貴州百靈(002424.SZ):與大醫生醫療簽訂戰略合作框架協議
格隆匯 12 月 15日丨貴州百靈(002424.SZ)公佈,公司於2020年12月15日與大醫生醫療股份有限公司(“大醫生醫療”)簽訂《戰略合作框架協議》。公司全資子公司貴州百靈中醫糖尿病醫院有限責任公司(“百靈糖尿病醫院”)與大醫生醫療簽訂《百靈大醫生糖尿病互聯網醫院業務合作協議》。
大醫生醫療為公司參與投資的重慶金浦醫療健康服務產業股權投資基金合夥企業(有限合夥)所投資的一家圍繞醫院、醫生、患者、保險、醫藥等打造一體化的互聯網醫療服務平台,業務板塊涵蓋互聯網醫療、健康管理、高端體檢等領域。
此次公司及全資子公司百靈糖尿病醫院與大醫生醫療簽訂協議,公司將與大醫生醫療的明醫明診互聯網醫院搭建線上糖尿病診療的獨家合作平台,進一步擴大“糖寧通絡”在全國市場的宣傳、學術推廣和患者應用工作,同時促進糖尿病慢病管理線上線下一體化發展,建立糖寧通絡依託於互聯網醫院系統的線上銷售網絡,打造貴州百靈糖尿病患者線上健康管理生態,為公司增加新的利潤增長點,提高公司的競爭力和持續盈利能力,對公司的戰略佈局起到積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.